All News about Citius Pharmaceuticals Inc
Analysts Hunt for Undervalued Biotech Stocks
July 17, 2024
Via Newsfile
Via AB Newswire
Exposures
Product Safety
Via Benzinga
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
April 18, 2024
Via News Direct
Topics
Death
Exposures
Death
Via Benzinga
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 24, 2023
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|